Letter to the Nevada Senate: Price Controls on Lower Cost Drugs is a Bad Idea

Dear Chairwoman Carlton: As a non-profit research organization representing consumers in Nevada and around the United States, we strongly oppose Nevada Senate Bill 380 (SB 380). As your Committee seeks much-needed remedies to the rising cost of health care, and specifically prescription drugs, we encourage you to resist efforts that directly or indirectly impose price […]